ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
35.71
-0.56%
US Tech 100
18,307.60
0.41%
S&P 500
5,307.01
-0.27%
US Dollar vs CAD
1.36884
-0.02%
Bitcoin
69,420.70
0.46%
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Vivos Therapeutics Inc (VVOS)

  7. Vivos Therapeutics Inc (VVOS) News

VVOS

Vivos Therapeutics (VVOS)

Vivos Therapeutics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:VVOS
DateTimeSourceHeadlineSymbolCompany
05/20/202412:04PMGlobeNewswire Inc.Consolidated Water Comments on ISS and Glass Lewis Reports and Urges Stockholders to Vote “FOR” Re-Election of Its Highly Qualified DirectorsNASDAQ:VVOSVivos Therapeutics Inc
05/17/20243:43PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:VVOSVivos Therapeutics Inc
05/15/20241:54PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:VVOSVivos Therapeutics Inc
05/14/20243:16PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:VVOSVivos Therapeutics Inc
05/14/20243:05PMGlobeNewswire Inc.Vivos Therapeutics Reports First Quarter 2024 Financial Results and Provides Operational UpdateNASDAQ:VVOSVivos Therapeutics Inc
05/14/20246:30AMGlobeNewswire Inc.Vivos Therapeutics Schedules Release of First Quarter 2024 Financial Results and Conference CallNASDAQ:VVOSVivos Therapeutics Inc
04/09/20246:30AMGlobeNewswire Inc.Vivos Therapeutics’ Flagship CARE Oral Medical Devices Receive Full Approval for Medicare ReimbursementNASDAQ:VVOSVivos Therapeutics Inc
03/28/20243:05PMGlobeNewswire Inc.Vivos Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Operational UpdateNASDAQ:VVOSVivos Therapeutics Inc
03/28/20246:30AMGlobeNewswire Inc.Vivos Therapeutics Schedules Release of Fourth Quarter and Full Year 2023 Financial Results and Conference CallNASDAQ:VVOSVivos Therapeutics Inc
02/15/20247:55AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:VVOSVivos Therapeutics Inc
02/15/20247:00AMGlobeNewswire Inc.Vivos Therapeutics Announces Exercise of Warrants for Approximately $4.0 Million Aggregate Gross ProceedsNASDAQ:VVOSVivos Therapeutics Inc
02/14/20244:42PMEdgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:VVOSVivos Therapeutics Inc
02/06/20246:30AMGlobeNewswire Inc.Vivos Therapeutics Highlights Significant Favorable Market Developments Creating Exciting New Growth OpportunitiesNASDAQ:VVOSVivos Therapeutics Inc
01/08/20246:30AMGlobeNewswire Inc.Vivos Therapeutics Sees Positive Preliminary Metrics Following Unprecedented FDA 510(k) Clearance of the Company’s Proprietary Oral Medical Devices to Treat Severe OSANASDAQ:VVOSVivos Therapeutics Inc
12/11/20236:30AMGlobeNewswire Inc.Vivos Therapeutics Presents Groundbreaking Event: “Empowering Women to Champion Airway”NASDAQ:VVOSVivos Therapeutics Inc
12/03/202311:15PMEdgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:VVOSVivos Therapeutics Inc
12/01/20233:12PMEdgar (US Regulatory)Form 424B1 - Prospectus [Rule 424(b)(1)]NASDAQ:VVOSVivos Therapeutics Inc
11/30/20233:05PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:VVOSVivos Therapeutics Inc
11/30/20233:03PMEdgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:VVOSVivos Therapeutics Inc
11/29/20236:30AMGlobeNewswire Inc.Vivos Therapeutics Receives First Ever FDA 510(k) Clearance for Oral Device Treatment of Severe Obstructive Sleep ApneaNASDAQ:VVOSVivos Therapeutics Inc
11/22/20233:46PMEdgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933NASDAQ:VVOSVivos Therapeutics Inc
11/14/20233:05PMGlobeNewswire Inc.Vivos Therapeutics Reports Third Quarter 2023 Financial Results and Provides Operational UpdateNASDAQ:VVOSVivos Therapeutics Inc
11/09/20233:30PMGlobeNewswire Inc.Vivos Therapeutics Schedules Release of Third Quarter 2023 Financial Results and Conference CallNASDAQ:VVOSVivos Therapeutics Inc
11/03/20234:00PMEdgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:VVOSVivos Therapeutics Inc
11/02/20234:10PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:VVOSVivos Therapeutics Inc
11/02/20234:00PMGlobeNewswire Inc.Vivos Therapeutics Closes $4 Million Private PlacementNASDAQ:VVOSVivos Therapeutics Inc
10/31/20237:00AMGlobeNewswire Inc.Vivos Therapeutics Announces Pricing of $4 Million Private Placement Priced At-the-Market Under Nasdaq RulesNASDAQ:VVOSVivos Therapeutics Inc
10/27/20233:15PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:VVOSVivos Therapeutics Inc
10/26/20236:30AMGlobeNewswire Inc.Vivos Therapeutics Announces Reverse Stock SplitNASDAQ:VVOSVivos Therapeutics Inc
10/24/20236:30AMGlobeNewswire Inc.Vivos Therapeutics Signs Nationwide Distribution Agreement with LincareNASDAQ:VVOSVivos Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:VVOS

Your Recent History

NASDAQ
NVDA
NVIDIA
USOTC
RDGL
Vivos (QB)
USOTC
ENZC
Enzolytics (PK)
NASDAQ
HOLO
MicroCloud Hologram
USOTC
CBIA
Canopus Biopharma (PK)
USOTC
UBQU
Ubiquitech Software (PK)
USOTC
DPLS
DarkPulse (PK)
USOTC
VPLM
Voip Pal Com (QB)
NASDAQ
RVNC
Revance Therapeutics
USOTC
SONGD
Music Licensing (PK)
AMEX
SPY
SPDR S&P 500
USOTC
GNCP
GNCC Capital (CE)
USOTC
BLEG
Branded Legacy (PK)
USOTC
AXXA
Exxe (PK)
NASDAQ
LWLG
Lightwave Logic
NASDAQ
FCEL
FuelCell Energy
Delayed Upgrade Clock
ADVFN Logo

Canada
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved